Welcome to Peer2Peer

A surgeon-led clinical education program focused on cataract and refractive surgery.

Search the content

Trending podcasts

Listen on:

View all

OMIDRIA Special - Innovations in Dropless Cataract Surgery Solutions

OMIDRIA Special - OMIDRIA Pearls from AECOS 2023

OMIDRIA Special - From Trial to OMIDRIA on board for Every Surgery: Experts Share Why

OMIDRIA Special - Performance and Clinical Outcomes of OMIDRIA in Cataract Surgery

OMIDRIA Special - Using OMIDRIA for Mitigating Risk in Cataract Surgery

OMIDRIA Special - An OMIDRIA Overview

Transforming Ophthalmology Practices with Dropless Solutions
Dr Donnenfeld, Dr Singh, Dr Houser, Dr Yeu

Cataract Surgery Pearls from Forward Thinking Ophthalmologists
Dr Donnenfeld, Dr Singh, Dr Houser, Dr Yeu

Optimizing Cataract Surgery: Surgeon Controlled Dropless Solutions
Dr Donnenfeld, Dr Singh, Dr Houser, Dr Yeu

Unlocking the Future: New Data on Dropless
Dr Donnenfeld, Dr Singh, Dr Houser, Dr Yeu

A Dropless Solution for the Forward-Thinking Ophthalmologist
Dr Donnenfeld, Dr Singh, Dr Houser, Dr Yeu

ASCRS Symposium Highlights: Dropless Solutions Tackling Cataract Surgery Challenges
Dr Donnenfeld, Dr Singh, Dr Houser, Dr Yeu

Dropless Strategies with OMIDRIA
Dr McCabe & Dr Singh

Modern Solution for Modern Cataract Surgery
Dr Endl

Dropless Cataract Surgery Regimens: The Future Is Bright
Dr Grupta

Dropless Cataract Regimens: Delivering a Patient Focused Experience
Dr Yeu

Trending publications / white papers

View all

Publication / Delivering a Dropless Pathway in Cataract Surgery

Kourtney Houser and John Hovanesian discuss how dropless therapy regimens with OMIDRIA® equal – and...

Publication / Blocking the Inflammatory Cascade

Dr. Donnenfeld sheds light on the myriad of benefits of integrating OMIDRIA in cataract...

Publication / Controlling postoperative inflammation and associated complications with OMIDRIA

Dr. Visco discusses the surgical and patient benefits of continuous intracameral administration of OMIDRIA.

Delivering a Dropless Pathway in Cataract Surgery

Kourtney Houser and John Hovanesian discuss how dropless therapy regimens with OMIDRIA® equal – and...

Blocking the Inflammatory Cascade

Dr. Donnenfeld sheds light on the myriad of benefits of integrating OMIDRIA in cataract...

Controlling postoperative inflammation and associated complications with OMIDRIA

Dr. Visco discusses the surgical and patient benefits of continuous intracameral administration of OMIDRIA.

INDICATIONS AND USAGE

OMIDRIA® is added to ophthalmic irrigating solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain.

IMPORTANT SAFETY INFORMATION

OMIDRIA must be added to irrigating solution prior to intraocular use.

OMIDRIA is contraindicated in patients with a known hypersensitivity to any of its ingredients.

Systemic exposure to phenylephrine may cause elevations in blood pressure.

Use OMIDRIA with caution in individuals who have previously exhibited sensitivities to acetylsalicylic acid, phenylacetic acid derivatives, and other nonsteroidal anti-inflammatory drugs (NSAIDs), or have a past medical history of asthma.

The most commonly reported adverse reactions at ≥ 2% are eye irritation, posterior capsule opacification, increased intraocular pressure, and anterior chamber inflammation.

Please see the Full Prescribing Information for OMIDRIA.

You are encouraged to report Suspected Adverse Reactions to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.